Sign up today!
A groundbreaking one-dose drug, lepodisiran, is turning the tide in the fight against genetic bad cholesterol. Its ability to reduce lipoprotein(a) levels drastically could redefine cardiovascular disease treatment. We’ll dive into the science of this promising therapy and what it means for patients worldwide.
Experimental Compound Shown to Block Effects of both Opioid and Non-Opioid Drugs Cancer mRNA Vaccine Completes Pivotal Trial Apple waste may find use in health-boosting chicken feed A New Low-Output Battery Could Last for 1000’s of Years and Power the Internet of Things A New Global Poverty Indicator is discovered. The most electrifying indicator in Economics.
The results showed that when the vaccine was combined with Merck's immunotherapy drug, Keytruda, the rate of melanoma recurrence decreased by 44%.